市場調查報告書
商品編碼
1399750
心律管理設備市場 - 按產品(心律調節器、去顫器、體外去顫器、心臟再同步治療設備),按應用、最終用途和預測,2023 - 2032 年Cardiac Rhythm Management Devices Market - By Product (Pacemakers, Defibrillators, External Defibrillator, Cardiac Resynchronization Therapy Devices), By Application, End-use & Forecast, 2023 - 2032 |
在全球老化的推動下,心律管理設備市場佔有率預計在 2023 年至 2032 年間將以超過 6.2% 的CAGR成長。為了解決與年齡相關的心臟問題,對起搏器和植入式心律轉復除顫器 (ICD) 等心律管理設備的需求不斷增加。例如,根據 CDC 的數據,2021 年,美國約有 695,000 人死於心臟病,即每 5 名死亡人數中就有 1 人死於心臟病。
持續的研發工作導致了更複雜、更有效的設備的推出,改善了患者的治療效果並鼓勵醫療保健提供者採用這些設備。智慧技術、遠端監控能力和設備小型化的整合將進一步促進行業前景。
整個心律管理設備產業根據產品、應用、最終用途和地區進行分類。
由於體外去顫器在解決心臟驟停方面發揮著至關重要的作用,其預計將在 2023 年和 2032 年顯著成長。隨著人們越來越認知到在危及生命的情況下及時干預的重要性,體外除顫器變得越來越容易使用且方便用戶使用。這些設備在公共設施中的廣泛使用,加上促進心肺復甦術和除顫器培訓的舉措,正在增強醫療保健專業人員和非專業人士的能力。
根據最終用途範圍,在全面的診斷和治療服務的支持下,心臟護理中心細分市場將在 2023 年至 2032 年期間為市場帶來可觀的收入。這些中心擁有的專業知識和先進的醫療技術提供有效和專業的護理,鼓勵心律管理設備作為治療計劃的基本要素。這些中心通常作為醫學研究和創新的中心。他們對臨床試驗的參與以及尖端技術的整合將進一步推動產品需求。
受預防性醫療保健偏好的推動,亞太地區心律管理設備市場預計到 2032 年將出現顯著成長,從而增加對心臟疾病的篩檢和早期發現。該地區充滿活力的經濟發展導致醫療保健意識的提高,從而提高了個人投資先進心臟護理技術的意願。醫療基礎設施的持續擴張將在未來幾年繼續影響亞太地區的市場動態。
Cardiac Rhythm Management Devices Market share is predicted to grow at a CAGR of over 6.2% between 2023 and 2032, driven by the aging global. The demand for cardiac rhythm management devices, such as pacemakers and implantable cardioverter-defibrillators (ICDs), rises to address age-related cardiac issues. For instance, as per CDC, in 2021, approximately 695,000 people in the United States died from heart disease-that is 1 in every 5 deaths.
Continuous R&D efforts have led to the introduction of more sophisticated and effective devices, enhancing patient outcomes and encouraging the adoption of these devices by healthcare providers. The integration of smart technologies, remote monitoring capabilities, and miniaturization of devices will further contribute to the industry's outlook.
The overall cardiac rhythm management devices industry is divided based on product, application, end-use & region.
External defibrillator segment is poised for a notable growth during 2023 and 2032, owing to its crucial role in addressing sudden cardiac arrests. With growing awareness regarding the importance of timely intervention in life-threatening situations, external defibrillators are becoming more accessible and user-friendly. The widespread use of these devices in public facilities, coupled with initiatives promoting CPR and defibrillator training, is empowering both healthcare professionals and laypersons.
As per end-use scope, cardiac care centers segment will generate notable revenues for the market during 2023-2032, backed by comprehensive diagnostic and treatment services. The expertise and advanced medical technologies available in these centers provide effective and specialized care, encouraging the incorporation of cardiac rhythm management devices as essential elements in treatment plans. These centers often serve as hubs for medical research & innovation. Their involvement in clinical trials and the integration of cutting-edge technologies will further propel the product demand.
Asia pacific cardiac rhythm management devices market is slated to witness a significant growth rate through 2032, favored by the preference for preventive healthcare, leading to increased screenings and early detection of cardiac conditions. The region's dynamic economic development results in a rise in healthcare awareness, contributing to an increased willingness among individuals to invest in advanced cardiac care technologies. The ongoing expansion of healthcare infrastructure will continue to shape the market dynamics in the APAC region in the coming years.